parthenolide has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Da, Y; Fu, S; Huang, W; Kong, Y; Li, Y; Na, D; Wang, D; Wang, H; Xue, Z; Yang, F; Yang, L; Zhang, L; Zhang, Q; Zhang, R | 1 |
| Auh, S; Blokh, L; Gagnon, I; Hamann, KJ; Long, C; Qin, Y | 1 |
2 other study(ies) available for parthenolide and Acute Disease
| Article | Year |
|---|---|
Parthenolide ameliorates Concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Concanavalin A; Cytokines; Disease Models, Animal; Hepatitis; Humans; Immunity, Cellular; Inflammation Mediators; Liver; Macrophages; Male; Mice; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Tumor Suppressor Protein p53 | 2016 |
TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; Electrophoretic Mobility Shift Assay; Eosinophils; Fas Ligand Protein; Humans; I-kappa B Kinase; Leukemia, Myeloid; NF-kappa B; Nitriles; Sesquiterpenes; Sulfones; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein | 2007 |